- Characterising the interaction between environmental and genetic (epigenetics) factors in determining diabetes and cardiometabolic diseases risk.
- Uncovering, testing, validating and enhancing biomarkers for diabetes and cardiometabolic disease risk screening and prediction.
- Investing potential novel therapeutic targets for diabetes and cardiometabolic diseases.
- Addressing diabetes and cardiometabolic diseases prevention and control challenges of mixed-ancestry South Africans.